Longeveron Announces Presentation of Clinical Data at the 2026 Alzheimer’s Association International Conference (AAIC) that Indicate Its Cellular Therapy Laromestrocel Reduced Neuroinflammation in P
Go back to Longeveron Announces Presentation of Clinical Data at the 2026 Alzheimer’s Association International Conference (AAIC) that Indicate Its Cellular Therapy Laromestrocel Reduced Neuroinflammation in P| LOGICVISION (NASDAQ: LGVN) | Delayed: 0.61 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.61 | 52 Week High | $1.62 | |||
| Open | $0.61 | 52 Week Low | $0.35 | |||
| Day High | $0.61 | P/E | N/A | |||
| Day Low | $0.61 | EPS | $-0.17 | |||
| Volume | 123 | |||||
| (NASDAQ: LGVNR) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $ | |||
| Open | $2.45 | 52 Week Low | $ | |||
| Day High | $0.00 | P/E | N/A | |||
| Day Low | $0.00 | EPS | $ | |||
| Volume | 23,525,480 | |||||
